These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37948576)

  • 1. A Patchy Prohibition: Product and Flavor Substitution After the Food and Drug Administration's Prioritized Enforcement Policy on Flavored E-cigarettes.
    Borowiecki M; Kim Y; Emery S
    Nicotine Tob Res; 2024 Apr; 26(5):527-535. PubMed ID: 37948576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions to hypothetical flavor bans among current users of flavored e-cigarettes.
    Yang Y; Lindblom EN; Ward KD; Salloum RG
    Transl Behav Med; 2023 Aug; 13(8):533-538. PubMed ID: 36694931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018-2019 Survey.
    Mok Y; Jeon J; Levy DT; Meza R
    Nicotine Tob Res; 2023 Feb; 25(3):541-552. PubMed ID: 36250607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ice Flavor-Related Discussions on Twitter: Content Analysis.
    Galimov A; Vassey J; Galstyan E; Unger JB; Kirkpatrick MG; Allem JP
    J Med Internet Res; 2022 Nov; 24(11):e41785. PubMed ID: 36449326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Food and Drug Administration enforcement policy on flavored e-cigarettes on the online popularity of disposable e-cigarettes: analyses of Google search query data.
    Boakye E; Dzaye O; Erhabor J; Osuji N; Obisesan O; Osei AD; Bhatnagar A; Robertson RM; Blaha MJ
    BMC Public Health; 2022 Oct; 22(1):1937. PubMed ID: 36258175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
    Baker RR; Pereira da Silva JR; Smith G
    Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teens Less Susceptible to Vaping When Restricted to Tobacco-Flavored E-cigarettes: Implications for Flavored Tobacco Policies.
    Helgertz S; Kingsbury J
    Nicotine Tob Res; 2023 Apr; 25(5):991-995. PubMed ID: 36455240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNA Damage in Electronic Cigarette Users.
    Tommasi S; Blumenfeld H; Besaratinia A
    Nicotine Tob Res; 2023 May; 25(6):1145-1154. PubMed ID: 36780924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Exposure to Food and Drug Administration E-cigarette Authorization Messages on Product Perceptions and Interest-An Experiment With Adults Who Smoke and Youth.
    Wackowski OA; Jeong M; Gratale SK; Weiger C; Chen-Sankey J; Strasser AA; Delnevo CD
    Nicotine Tob Res; 2024 Nov; 26(12):1666-1675. PubMed ID: 38836598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retail violations of sales to minors on e-cigarettes and cigars.
    Dai H; Hao J; Catley D
    Public Health; 2020 Oct; 187():36-40. PubMed ID: 32889230
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.